Literature DB >> 6687429

Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with dazoxiben hydrochloride (UK 37,248-01).

M J Randall, R I Wilding.   

Abstract

1 Acute thrombosis was induced in the carotid arteries of anaesthetized rabbits by local electrical stimulation (1 mA for 2 min) of the vessel wall. Histological findings confirmed the platelet-rich composition of the thrombus. Platelet accumulation at the stimulus site was quantitated with 111Indium-labelling of autologous platelets. 2 In rabbits injected intravenously with either the thromboxane synthetase inhibitor dazoxiben 2 mg/kg or aspirin 10 mg/kg, accumulation of labelled platelets was considerably reduced. Animals which received vehicle injection only, showed no such reduced thrombus formation. 3 In separate experiments in anaesthetized rabbits, the levels of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha in clotting blood were measured in blood samples taken from animals which had received the above drug treatments. Aspirin markedly reduced the production of both arachidonate metabolites. In contrast, dazoxiben almost totally inhibited TXB2 production but caused a 3.5-fold increase in the levels of 6-keto PGF1 alpha. 4 These findings demonstrate an antithrombotic effect and confirm the mechanistic selectivity of a thromboxane synthetase inhibitor.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6687429      PMCID: PMC1427690          DOI: 10.1111/j.1365-2125.1983.tb02107.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  111-Indium labelled canine platelets.

Authors:  A R Wilkinson; R J Hawker; L M Hawker
Journal:  Thromb Res       Date:  1978-08       Impact factor: 3.944

Review 2.  Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.

Authors:  S Moncada; J R Vane
Journal:  Br Med Bull       Date:  1978-05       Impact factor: 4.291

3.  Selective inhibition of thromboxane synthetase by dazoxiben increases prostacyclin production by leukocytes in angina patients and healthy volunteers.

Authors:  M J Parry; M J Randall; H M Tyler; E Myhre; J Dale; E Thaulow
Journal:  Lancet       Date:  1982-07-17       Impact factor: 79.321

4.  Administration to man of UK-37,248-01, a selective inhibitor of thromboxane synthetase.

Authors:  H M Tyler; C A Saxton; M J Parry
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

5.  Inhibition of thromboxane synthetase does not necessarily prevent platelet aggregation.

Authors:  V Bartele; C Cerletti; A Schiepatti; G di Minno; G de Gaetano
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

6.  Endogenous prostacyclin contributes to the efficacy of a thromboxane synthetase inhibitor for preventing coronary artery thrombosis.

Authors:  J W Aiken; R J Shebuski; O V Miller; R R Gorman
Journal:  J Pharmacol Exp Ther       Date:  1981-11       Impact factor: 4.030

7.  UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.

Authors:  M J Randall; M J Parry; E Hawkeswood; P E Cross; R P Dickinson
Journal:  Thromb Res       Date:  1981 Jul 1-15       Impact factor: 3.944

8.  Differential effects of two doses of aspirin on platelets-vessel wall introduction in vivo.

Authors:  K K Wu; Y C Chen; E Fordham; C H Ts'Ao; G Rayudu; D Matayoshi
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

9.  Thromboxane synthetase inhibition as antithrombotic strategy.

Authors:  J Vermylen; G Defreyn; L O Carreras; S J Machin; J Van Schaeren; M Verstraete
Journal:  Lancet       Date:  1981-05-16       Impact factor: 79.321

10.  Thrombogenic effect of high-dose aspirin in rabbits. Relationship to inhibition of vessel wall synthesis of prostaglandin I2-like activity.

Authors:  J G Kelton; J Hirsh; C J Carter; M R Buchanan
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

View more
  3 in total

Review 1.  Nuclear medicine and atherosclerosis.

Authors:  H Sinzinger; I Virgolini
Journal:  Eur J Nucl Med       Date:  1990

2.  Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.

Authors:  D J Fitzgerald; J Fragetta; G A FitzGerald
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

3.  Pilot study of fluvoxamine treatment for climacteric symptoms in Japanese women.

Authors:  Akira Oishi; Yoshiko Mochizuki; Reiko Otsu; Noriyuki Inaba
Journal:  Biopsychosoc Med       Date:  2007-06-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.